Urothelial Cancer
Showing 1 - 25 of 48
Adults in South Korea With Cancer Who Receive PADCEV Injection
Recruiting
- Urothelial Cancer
- Enfortumab Vedotin
-
Seoul, Korea, Republic ofKR82004
Aug 22, 2023
Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ) Trial in Worldwide (Autologous genetically modified
Recruiting
- Endometrial Cancer
- +8 more
- Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks
-
Orlando, Florida
- +21 more
Feb 2, 2023
Urothelial Cancer and Rare Genitourinary Tract Malignancies
Recruiting
- Urothelial Cancer
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Advanced Solid Tumors, Gastric Cancer, Gastroesophageal Junction Cancer Trial in Japan, United States (PF-07265028, Sasanlimab)
Recruiting
- Advanced Solid Tumors
- +5 more
- PF-07265028
- Sasanlimab
-
Scottsdale, Arizona
- +7 more
Jan 23, 2023
Urothelial Cancer, Bladder Cancer, Genitourinary Cancer Trial run by the NCI (M7824, M9241, Stereotactic body radiation therapy
Recruiting
- Urothelial Cancer
- +4 more
- M7824
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Urothelial Cancer Trial in Beijing (Atezolizumab, RO7247669, Tiragolumab)
Recruiting
- Urothelial Cancer
- Atezolizumab
- +2 more
-
Beijing, ChinaBeijing Cancer Hospital
Jan 18, 2023
Urothelial Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Gemcitabine)
Recruiting
- Urothelial Cancer
- Nivolumab
- +4 more
-
Birmingham, Alabama
- +196 more
Jan 17, 2023
Advanced Malignancies, NSCLC, Ovarian Cancer Trial in Worldwide (Avelumab, Lorlatanib, Talazoparib)
Recruiting
- Advanced Malignancies
- +4 more
- Avelumab
- +7 more
-
Fayetteville, Arkansas
- +61 more
Jan 10, 2023
Carcinoma, Transitional Cell, Urinary Bladder Tumors, Urologic Tumors Trial in Worldwide (enfortumab vedotin (EV),
Active, not recruiting
- Carcinoma, Transitional Cell
- +6 more
- enfortumab vedotin (EV)
- +4 more
-
Anchorage, Alaska
- +105 more
Dec 19, 2022
Non Small Cell Lung Cancer, Urothelial Cancer, Ovarian Cancer Trial in United States (XB002, Nivolumab)
Recruiting
- Non Small Cell Lung Cancer
- +9 more
- XB002
- +2 more
-
Saint Louis, Missouri
- +4 more
Dec 12, 2022
Colorectal Cancer, NSCLC, Triple Negative Breast Cancer Trial in Spain, United Kingdom, United States (GEN1029
Terminated
- Colorectal Cancer
- +6 more
- GEN1029 (HexaBody®-DR5/DR5)
-
New Haven, Connecticut
- +5 more
Nov 11, 2022
Urothelial Cancer Trial in Worldwide (MEDI4736 (Durvalumab), Tremelimumab, Cisplatin)
Active, not recruiting
- Urothelial Cancer
- MEDI4736 (Durvalumab)
- +4 more
-
Los Angeles, California
- +221 more
Nov 2, 2022
Urothelial Cancer Trial in Worldwide (Avelumab, Best Supportive Care, Following the planned interim analysis for this study:
Active, not recruiting
- Urothelial Cancer
- Avelumab
- +2 more
-
Aurora, Colorado
- +370 more
Oct 24, 2022
Non Small Cell Lung Cancer, Urothelial Cancer, Renal Cell Carcinoma Trial in Worldwide (INCB086550)
Active, not recruiting
- Non Small Cell Lung Cancer
- +4 more
-
Burgas, Bulgaria
- +19 more
Oct 20, 2022
NSCLC, Urothelial Cancer Trial in Worldwide (Avelumab 800 mg in combination with pemetrexed / carboplatin, Avelumab 800 mg in
Active, not recruiting
- Non-small Cell Lung Cancer
- Urothelial Cancer
- Avelumab 800 mg in combination with pemetrexed / carboplatin
- +3 more
-
Tucson, Arizona
- +45 more
Oct 13, 2022
Urothelial Cancer, Metastatic Urothelial Carcinoma, Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter Trial in
Recruiting
- Urothelial Cancer
- +3 more
- Sacituzumab Govitecan (SG)
- Enfortumab vedotin-ejfv (EV)
-
Boston, MassachusettsDana Farber Cancer Institute
Sep 28, 2022
Care of Urothelial Cancer Patient and Prospective Procurement of
Recruiting
- Bladder Cancer
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
NSCLC, Urothelial Cancer Trial in Worldwide (Avelumab (MSB0010718C), Axitinib (AG-013736))
Active, not recruiting
- Non-Small Cell Lung Cancer
- Urothelial Cancer
- Avelumab (MSB0010718C)
- Axitinib (AG-013736)
-
Glendale, Arizona
- +36 more
Aug 16, 2022